Expression of glycolipids bearing lewis phenotypes in tissues and cultured cells of human gynecological cancers

Kyoko Takehara, Kaneyuki Kubushiro, Kazushige Kiguchi, Isamu Ishiwata, Katsumi Tsukazaki, Shiro Nozawa, Masao Iwamori

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Transformation-associated expression of Leb (Lewis antigen-b) or LeY in human colorectal carcinomas has been well described. To examine the expression of glycosphingolipids (GSLs) bearing Lewis-phenotypes in human gynecological carcinoma-derived cells, we determined the concentrations of all GSLs. Although neither Leb nor LeY was present in HEC-108 cells established from the poorly differentiated type of endometrial adenocarcinoma, other cell lines from moderately or well-differentiated types expressed either Leb or LeY, or both, at concentrations of 0.01 to 0.03 μg per mg of dry cells, which comprised 0.3 to 1.3% of the total GSLs. In the cervical and ovarian carcinoma-derived cell lines, Lewis phenotypes tended to be carried by nLc4Cer, which was accumulated in the cells without sialylation or fucosylation. These results indicated that expression of Leb- or LeY-phenotypes was strongly dependent on the metabolic ability to supply the precursor GSLs. Both Leb and LeY were successfully detected by monoclonal antibody MSN-1, which was a useful probe for the simultaneous detection of Leb and LeY. On application of MSN-1, either Leb or LeY was detected in tissues from patients with well- and moderately differentiated types of endometrial adenocarcinoma at concentrations of 0.01 to 0.04 μg per mg of dry tissues, but not in the tissues of poorly differentiated type. Normal endometria at the follicular and luteal phases also contained the antigens, but the concentrations and the frequency of antigen expression were lower than those in the well- and moderately differentiated types of endometrial adenocarcinoma.

Original languageEnglish
Pages (from-to)1129-1137
Number of pages9
JournalJapanese Journal of Cancer Research
Volume93
Issue number10
Publication statusPublished - 2002 Oct 1

Fingerprint

Glycolipids
Cultured Cells
Phenotype
Antigens
Glycosphingolipids
Neoplasms
Adenocarcinoma
Carcinoma
Cell Line
Follicular Phase
Luteal Phase
Endometrium
Colorectal Neoplasms
Monoclonal Antibodies

Keywords

  • Fast atom bombardment mass spectrometry
  • Glycosphingolipid
  • Lewis antigen
  • TLC-immunostaining
  • Uterine endometrial adenocarcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Takehara, K., Kubushiro, K., Kiguchi, K., Ishiwata, I., Tsukazaki, K., Nozawa, S., & Iwamori, M. (2002). Expression of glycolipids bearing lewis phenotypes in tissues and cultured cells of human gynecological cancers. Japanese Journal of Cancer Research, 93(10), 1129-1137.

Expression of glycolipids bearing lewis phenotypes in tissues and cultured cells of human gynecological cancers. / Takehara, Kyoko; Kubushiro, Kaneyuki; Kiguchi, Kazushige; Ishiwata, Isamu; Tsukazaki, Katsumi; Nozawa, Shiro; Iwamori, Masao.

In: Japanese Journal of Cancer Research, Vol. 93, No. 10, 01.10.2002, p. 1129-1137.

Research output: Contribution to journalArticle

Takehara, K, Kubushiro, K, Kiguchi, K, Ishiwata, I, Tsukazaki, K, Nozawa, S & Iwamori, M 2002, 'Expression of glycolipids bearing lewis phenotypes in tissues and cultured cells of human gynecological cancers', Japanese Journal of Cancer Research, vol. 93, no. 10, pp. 1129-1137.
Takehara K, Kubushiro K, Kiguchi K, Ishiwata I, Tsukazaki K, Nozawa S et al. Expression of glycolipids bearing lewis phenotypes in tissues and cultured cells of human gynecological cancers. Japanese Journal of Cancer Research. 2002 Oct 1;93(10):1129-1137.
Takehara, Kyoko ; Kubushiro, Kaneyuki ; Kiguchi, Kazushige ; Ishiwata, Isamu ; Tsukazaki, Katsumi ; Nozawa, Shiro ; Iwamori, Masao. / Expression of glycolipids bearing lewis phenotypes in tissues and cultured cells of human gynecological cancers. In: Japanese Journal of Cancer Research. 2002 ; Vol. 93, No. 10. pp. 1129-1137.
@article{49a4fa28cd274bddb6b6719730feaf47,
title = "Expression of glycolipids bearing lewis phenotypes in tissues and cultured cells of human gynecological cancers",
abstract = "Transformation-associated expression of Leb (Lewis antigen-b) or LeY in human colorectal carcinomas has been well described. To examine the expression of glycosphingolipids (GSLs) bearing Lewis-phenotypes in human gynecological carcinoma-derived cells, we determined the concentrations of all GSLs. Although neither Leb nor LeY was present in HEC-108 cells established from the poorly differentiated type of endometrial adenocarcinoma, other cell lines from moderately or well-differentiated types expressed either Leb or LeY, or both, at concentrations of 0.01 to 0.03 μg per mg of dry cells, which comprised 0.3 to 1.3{\%} of the total GSLs. In the cervical and ovarian carcinoma-derived cell lines, Lewis phenotypes tended to be carried by nLc4Cer, which was accumulated in the cells without sialylation or fucosylation. These results indicated that expression of Leb- or LeY-phenotypes was strongly dependent on the metabolic ability to supply the precursor GSLs. Both Leb and LeY were successfully detected by monoclonal antibody MSN-1, which was a useful probe for the simultaneous detection of Leb and LeY. On application of MSN-1, either Leb or LeY was detected in tissues from patients with well- and moderately differentiated types of endometrial adenocarcinoma at concentrations of 0.01 to 0.04 μg per mg of dry tissues, but not in the tissues of poorly differentiated type. Normal endometria at the follicular and luteal phases also contained the antigens, but the concentrations and the frequency of antigen expression were lower than those in the well- and moderately differentiated types of endometrial adenocarcinoma.",
keywords = "Fast atom bombardment mass spectrometry, Glycosphingolipid, Lewis antigen, TLC-immunostaining, Uterine endometrial adenocarcinoma",
author = "Kyoko Takehara and Kaneyuki Kubushiro and Kazushige Kiguchi and Isamu Ishiwata and Katsumi Tsukazaki and Shiro Nozawa and Masao Iwamori",
year = "2002",
month = "10",
day = "1",
language = "English",
volume = "93",
pages = "1129--1137",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Expression of glycolipids bearing lewis phenotypes in tissues and cultured cells of human gynecological cancers

AU - Takehara, Kyoko

AU - Kubushiro, Kaneyuki

AU - Kiguchi, Kazushige

AU - Ishiwata, Isamu

AU - Tsukazaki, Katsumi

AU - Nozawa, Shiro

AU - Iwamori, Masao

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Transformation-associated expression of Leb (Lewis antigen-b) or LeY in human colorectal carcinomas has been well described. To examine the expression of glycosphingolipids (GSLs) bearing Lewis-phenotypes in human gynecological carcinoma-derived cells, we determined the concentrations of all GSLs. Although neither Leb nor LeY was present in HEC-108 cells established from the poorly differentiated type of endometrial adenocarcinoma, other cell lines from moderately or well-differentiated types expressed either Leb or LeY, or both, at concentrations of 0.01 to 0.03 μg per mg of dry cells, which comprised 0.3 to 1.3% of the total GSLs. In the cervical and ovarian carcinoma-derived cell lines, Lewis phenotypes tended to be carried by nLc4Cer, which was accumulated in the cells without sialylation or fucosylation. These results indicated that expression of Leb- or LeY-phenotypes was strongly dependent on the metabolic ability to supply the precursor GSLs. Both Leb and LeY were successfully detected by monoclonal antibody MSN-1, which was a useful probe for the simultaneous detection of Leb and LeY. On application of MSN-1, either Leb or LeY was detected in tissues from patients with well- and moderately differentiated types of endometrial adenocarcinoma at concentrations of 0.01 to 0.04 μg per mg of dry tissues, but not in the tissues of poorly differentiated type. Normal endometria at the follicular and luteal phases also contained the antigens, but the concentrations and the frequency of antigen expression were lower than those in the well- and moderately differentiated types of endometrial adenocarcinoma.

AB - Transformation-associated expression of Leb (Lewis antigen-b) or LeY in human colorectal carcinomas has been well described. To examine the expression of glycosphingolipids (GSLs) bearing Lewis-phenotypes in human gynecological carcinoma-derived cells, we determined the concentrations of all GSLs. Although neither Leb nor LeY was present in HEC-108 cells established from the poorly differentiated type of endometrial adenocarcinoma, other cell lines from moderately or well-differentiated types expressed either Leb or LeY, or both, at concentrations of 0.01 to 0.03 μg per mg of dry cells, which comprised 0.3 to 1.3% of the total GSLs. In the cervical and ovarian carcinoma-derived cell lines, Lewis phenotypes tended to be carried by nLc4Cer, which was accumulated in the cells without sialylation or fucosylation. These results indicated that expression of Leb- or LeY-phenotypes was strongly dependent on the metabolic ability to supply the precursor GSLs. Both Leb and LeY were successfully detected by monoclonal antibody MSN-1, which was a useful probe for the simultaneous detection of Leb and LeY. On application of MSN-1, either Leb or LeY was detected in tissues from patients with well- and moderately differentiated types of endometrial adenocarcinoma at concentrations of 0.01 to 0.04 μg per mg of dry tissues, but not in the tissues of poorly differentiated type. Normal endometria at the follicular and luteal phases also contained the antigens, but the concentrations and the frequency of antigen expression were lower than those in the well- and moderately differentiated types of endometrial adenocarcinoma.

KW - Fast atom bombardment mass spectrometry

KW - Glycosphingolipid

KW - Lewis antigen

KW - TLC-immunostaining

KW - Uterine endometrial adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0036807147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036807147&partnerID=8YFLogxK

M3 - Article

C2 - 12417043

AN - SCOPUS:0036807147

VL - 93

SP - 1129

EP - 1137

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 10

ER -